SEURAT Documentation (old)

Please note that by downloading any of the password protected documentation files for Seurat that you are agreeing to our

terms and conditions

Version 5.5.3 (Choose: 6.0.2 6.0.1 6.0 5.6.3 )
SEURAT Windows Quick Start Guide HTML Adobe PDF
SEURAT Installation Guide HTML Adobe PDF
SEURAT Administrators Guide HTML Adobe PDF
SEURAT Users Guide HTML Adobe PDF
SEURAT Search Portal Developer's Guide HTML Adobe PDF
SEURAT Form Building Guide HTML Adobe PDF
SEURAT Configuration and Database Mapping Guide HTML Adobe PDF
SEURAT Native Database Guide
(Paying customers only)
HTML Adobe PDF
Configuring SEURAT to use LDAP HTML Adobe PDF
Upgrading your database tables for use with SEURAT 5.3 HTML  
SEURAT API Developers Guide HTML Adobe PDF

SEURAT can be easily configured, without code changes, to access the drug discovery and development database of your choice through a "meta-data" driven configuration file. You can also add access to the data in new database tables after you have successfully deployed SEURAT at your site.

All you need to do is tell SEURAT (through its "meta-data" mapping file) which tables and columns of your database contain representations of the entities Project, Compound, Structure, Lot, Sample, Assay Results, Notebook and Scientist and how to navigate from one table to the next and SEURAT will do the rest.

Contact Us for more information about how SEURAT can be configured to access your particular database.

Affordability

Tired of paying Big Pharma prices for software tools? SEURAT is the Big Pharma tool at the small pharma price.
Learn more »

Scalability

Have hundreds of users and multiple databases? SEURAT can handle it.
Learn more »

Interoperability

Have home-grown or 3rd party tools? SEURAT can share data with them.
Learn more »

Easy to Config & Maintain

Tired of overblown tools requiring a lot of your own IT staff to install, configure and maintain? SEURAT makes life easy.
Learn more »

Customers

Two top 15 Pharma deployments. Over 1000 users accross both biotech and pharma.
Learn more »

Newsletter

Nov 2009 »